Cite
HARVARD Citation
Calcaterra, I. et al. (2022). An untargeted lipidomic analysis reveals depletion of several phospholipid classes in patients with familial hypercholesterolemia on treatment with Evolocumab®. Atherosclerosis. pp. 36-. [Online].